Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The Journal of Clinical Investigation|February 1, 1986
Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragmentM Schapira, M A Ramus, S Jallat, et al.FEBS Letters|November 24, 1986
RNA structural elements for expression in Escherichia coli. Alpha 1-antitrypsin synthesis using translation control elements based on the cII ribosome-binding site of phage lambdaL H Tessier, S Jallat, M Sauvageot, et al.Revue Francaise De Transfusion Et Immuno-Hematologie|September 1, 1986
Antiprotease targeting: altered specificity of alpha 1-antitrypsin by amino acid replacement at the reactive centreS Jallat, L H Tessier, A Benavente, et al.Nature|January 10, 1985
Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosisM Courtney, S Jallat, L H Tessier, et al.The EMBO Journal|October 1, 1990
Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell linesS Jallat, F Perraud, W Dalemans, et al.FEBS Letters|November 26, 1990
Sulphation of hirudin in BHK cellsT Skern, R Bischoff, S Jallat, et al.Protein Engineering|October 1, 1986
Altered specificities of genetically engineered alpha 1 antitrypsin variantsS Jallat, D Carvallo, L H Tessier, et al.The Journal of Clinical Investigation|August 1, 1987
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragmentM Schapira, M A Ramus, B Waeber, et al.The Journal of Clinical Investigation|November 1, 1987
Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastaseR C Hubbard, F Ogushi, G A Fells, et al.Biochimie|July 1, 1985
Use of synthetic oligonucleotides in gene isolation and manipulationA Balland, M Courtney, S Jallat, et al.Pageof 2